[ACRX] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -1.83%
YoY- -51.04%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 4,531 1,924 71 407 224 40 0 -
PBT -11,092 -8,896 -10,575 -17,447 -6,596 -4,607 -3,323 22.22%
Tax -2,083 777 2,215 -9,273 248 144 228 -
NP -11,092 -8,896 -10,575 -17,447 -7,194 -4,763 -3,537 20.96%
Tax Rate - - - - - - - -
Total Cost 15,623 10,820 10,646 17,854 7,418 4,803 3,537 28.06%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -244.80 -462.37 -14,894.37 -4,286.73 -3,211.61 -11,907.50 0.00 -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -4.90 -4.01 -4.88 -9.36 -6.98 -4.92 -108.23 -40.27%
EPS Diluted -4.90 -4.01 -4.77 -9.36 -6.98 -4.92 -108.23 -40.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.